Substance or medication-induced anxiety disorder: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 17: Line 17:
===DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>===
===DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>===
{{cquote|
{{cquote|
*A.[[Panic attacks]] or [[anxiety]] is predominant in the clinical picture.
*A. [[Panic attacks]] or [[anxiety]] is predominant in the clinical picture.


'''''AND'''''
'''''AND'''''


*B.There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):
*B. There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):


:*1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
:*1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.


:*2.The involved substance/medication is capable of producing the symptoms in Criterion A.
:*2. The involved substance/medication is capable of producing the symptoms in Criterion A.


'''''AND'''''
'''''AND'''''


*C.The disturbance is not better explained by an [[anxiety disorder]] that is not substance/medication-induced. Such evidence of an independent [[anxiety disorder]] could include
*C. The disturbance is not better explained by an [[anxiety disorder]] that is not substance/medication-induced. Such evidence of an independent [[anxiety disorder]] could include
the following:
the following:


Line 37: Line 37:
'''''AND'''''
'''''AND'''''


*D.The disturbance does not occur exclusively during the course of a [[delirium]].
*D. The disturbance does not occur exclusively during the course of a [[delirium]].


'''''AND'''''
'''''AND'''''


*E.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
*E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.


<SMALL>''Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention .''</SMALL>
<SMALL>''Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention.''</SMALL>
}}
}}


Revision as of 16:44, 13 November 2014

Template:Anxiety disorder Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Differential Diagnosis

Epidemiology and Demographics

Prevalence

The prevalence of substance or medication-induced anxiety disorder is not clear in the overall population.[1]

Diagnostic Criteria

DSM-V Diagnostic Criteria for Substance/Medication-Induced Anxiety Disorder [1]

“

AND

  • B. There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):
  • 1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.
  • 2. The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

  • C. The disturbance is not better explained by an anxiety disorder that is not substance/medication-induced. Such evidence of an independent anxiety disorder could include

the following:

  • The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication: or there is other evidence suggesting the existence of an independent non-substance/medication-induced anxiety disorder

(e.g., a history of recurrent non-substance/medication-related episodes).

AND

  • D. The disturbance does not occur exclusively during the course of a delirium.

AND

  • E. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and they are sufficiently severe to warrant clinical attention.

”

References

  1. ↑ 1.0 1.1 1.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Substance_or_medication-induced_anxiety_disorder&oldid=1041067"